title: Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer.
authors.forename: L D
authors.initials: LD
authors.lastname: Locati
authors.forename: G
authors.initials: G
authors.lastname: Rinaldi
authors.forename: P
authors.initials: P
authors.lastname: Bossi
authors.forename: G P
authors.initials: GP
authors.lastname: Dagrada
authors.forename: P
authors.initials: P
authors.lastname: Quattrone
authors.forename: G
authors.initials: G
authors.lastname: Cantú
authors.forename: L
authors.initials: L
authors.lastname: Licitra
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018734:Genes, erbB-2; D006801:Humans; D012468:Salivary Gland Neoplasms / Q000188:drug therapy*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab